| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.35B | 49.04B | 45.58B | 45.00B | 37.36B | 32.21B |
| Gross Profit | 25.12B | 23.91B | 22.76B | 22.56B | 17.85B | 14.87B |
| EBITDA | 13.02B | 12.70B | 13.45B | 13.47B | 10.26B | 8.13B |
| Net Income | 7.91B | 8.01B | 8.38B | 8.67B | 5.96B | 4.69B |
Balance Sheet | ||||||
| Total Assets | 93.83B | 92.76B | 88.59B | 79.75B | 71.61B | 64.33B |
| Cash, Cash Equivalents and Short-Term Investments | 22.93B | 23.25B | 21.59B | 22.02B | 21.50B | 15.93B |
| Total Debt | 2.00B | 3.33B | 3.20B | 3.11B | 3.56B | 3.80B |
| Total Liabilities | 15.44B | 15.26B | 16.14B | 16.36B | 14.75B | 11.71B |
| Stockholders Equity | 78.39B | 77.50B | 72.45B | 63.38B | 56.16B | 51.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.46B | 460.10M | 4.14B | 8.45B | 1.47B |
| Operating Cash Flow | 0.00 | 6.30B | 2.61B | 5.19B | 9.25B | 4.09B |
| Investing Cash Flow | 0.00 | -650.16M | -2.46B | -648.02M | -2.57B | -2.76B |
| Financing Cash Flow | 0.00 | -4.17B | -2.46B | -4.26B | -2.95B | -2.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥74.98B | 8.04 | ― | 0.82% | 7.10% | 36.47% | |
76 Outperform | ¥252.98B | 14.78 | ― | 2.42% | 9.55% | 9.52% | |
74 Outperform | ¥11.14B | 8.12 | ― | 3.98% | 4.35% | 7.25% | |
73 Outperform | ¥142.22B | 14.99 | ― | 1.39% | 11.23% | 16.49% | |
73 Outperform | ¥2.58T | 19.24 | 8.35% | 1.77% | 5.39% | 4.89% | |
64 Neutral | ¥613.57B | 16.50 | ― | 2.14% | 7.73% | 30.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |